Electroporation Instruments Market, by Product Type (Instruments (Total Electroporation System, Transfection System, and Microbial Electroporation System) and Accessories (Electroporated Cuvettes, Electrodes, Volume Chambers, and Others)), by Application

Electroporation Instruments Market, by Product Type (Instruments (Total Electroporation System, Transfection System, and Microbial Electroporation System) and Accessories (Electroporated Cuvettes, Electrodes, Volume Chambers, and Others)), by Application (Protein Production, Therapeutic Delivery, and Biomedical Research), by End User (Hospital Laboratories, Research & Academic Institutes, and Biotechnology or Pharmaceutical Industries), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Electroporation is used to introduce macromolecules such as proteins into cells, either in vivo or in vitro, by using brief electric pulses that cause momentary and reversible permeabilization of the cell membrane.
Electroporation of biological membranes has a wide range of applications in molecular biology and medicine such as intravascular drug and gene delivery using electroporation catheters, electro-insertion of molecules into membranes, intraocular drug and gene delivery, and transdermal drug delivery. Several in-vitro and in-vivo experimental studies have been carried out to determine the mechanisms of electroporation action in various types of membranes.
Electroporation has also proven to be a promising technique for targeted drug delivery in cancer therapy.

Market Dynamics
Market players are involved in research and development activities related to electroporation devices, this could contribute to the growth of the global electroporation instruments market over the forecast period. For instance, on April 02, 2019, OncoSec Medical Inc., an enterprise growing novel cancer immunotherapies based in New Jersey, U.S., presented pre-clinical data highlighting its novel anti-tumor product candidate, SPARK, and its advanced electroporation generator, APOLLO in a poster presentation at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta, Georgia. The poster, entitled, "Intratumoral electroporation of plasmid IL-12 and CXCL9 with membrane-bound anti-CD3 elicits robust anti-tumor immunity," provided new preclinical statistics demonstrating strong anti-tumor responses driven by way of considerable improvements made to OncoSec's proprietary cancer immunotherapy platform.

Market players focusing on clinical agreements is expected to strengthen their position in the global electroporation instruments market. For instance, on October 07, 2019, MaxCyte, Inc., a global cell-based therapies and life sciences company based in Maryland U.S., and Editas Medicine Inc., a leading genome editing company based in Massachusetts, U.S., announced a new clinical and commercial license agreement. Editas Medicine will advance engineered cell medicines using MaxCyte's Flow Electroporation technology and ExPERT instruments, including EDIT-301, an experimental CRISPR medicine designed to treat sickle cell disease and beta-thalassemia indefinitely.

Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, which is expected to drive the growth of the global electroporation instruments market. For instance, on January 19, 2021, Sirtex Medical U.S. Holdings Inc., a leading manufacturer of targeted cancer therapies, announced a step forward in its strategic collaboration with OncoSec Medical Inc., a biotechnology company, relating to OncoSec's lead product candidate TAVO (tavokinogene telseplasmid) and its electroporation (EP) gene delivery system. Sirtex after the collaboration has the option to acquire the right to co-promote TAVO in the U.S. and its related EP gene delivery system in the lead indication of treating anti-PD-1 refractory locally advanced or metastatic melanoma.

Key features of the study:
This report provides an in-depth analysis of global electroporation instruments market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global electroporation instruments market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Harvard Bioscience Inc. (BTX), Celetrix LLC, Mirus Bio LLC, Merck KGaA, Eppendorf AG, MaxCyte Inc., BEX Co. Ltd., and Lonza Group
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global electroporation instruments market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global electroporation instruments market

Detailed Segmentation:
Global Electroporation Instruments Market, By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others
Global Electroporation Instruments Market, By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
Global Electroporation Instruments Market, By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries
Global Electroporation Instruments Market, By Region:
North America
By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others
By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries
By Country:
U.S.
Canada
Latin America
By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others
By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others
By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others

By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others

By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Instruments
Total Electroporation System
Transfection System
Microbial Electroporation System
Accessories
Electroporated Cuvettes
Electrodes
Volume Chambers
Others

By Application:
Protein Production
Therapeutic Delivery
Biomedical Research
By End User:
Hospital Laboratories
Research & Academic Institutes
Biotechnology or Pharmaceutical Industries

By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Bio-Rad Laboratories*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Thermo Fisher Scientific Inc.
Harvard Bioscience Inc. (BTX)
Celetrix LLC
Mirus Bio LLC
Merck KGaA
Eppendorf AG
MaxCyte Inc.
BEX Co. Ltd.
Lonza Group.

“*” marked represents similar segmentation in other categories in the respective section.